Type 2 EOCs, including high-grade serous carcinoma (HGSC), carcinosarcoma, and undifferentiated carcinoma, are typically characterized by mutations in genes such as tumor protein P53 (TP53) and BRCA1/2. The gene discussed is TP53; the disease is carcinosarcoma.